This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nickoloff, B. J. Articles by Strieter, R. M. Search for Related Content PubMed PubMed Citation Articles by Nickoloff, B. J. Articles by Strieter, R. M.

American Journal of Pathology, Vol 146, 580-588, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model

BJ Nickoloff, SL Kunkel, M Burdick and RM Strieter
Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602.

Research into the cause and pathophysiological mechanisms underlying expression of psoriatric skin lesions has been hampered by lack of an appropriate animal model for this common and enigmatic cutaneous disease. These studies characterize normal skin, pre-psoriatic skin, and psoriatic plaque skin samples transplanted onto severe combined immunodeficiency mice. In this report we document that 1), normal, prepsoriatic, and psoriatic plaque keratome skin samples can be transplanted onto severe combined immunodeficiency mice reliably with high rates of graft survival (> 85%) and with reproducible changes consistently observed over prolonged periods of engraftment; 2), after transplantation, by clinical assessment and routine light microscopy, normal skin remained essentially normal whereas pre-psoriatic skin became thicker, and psoriatic plaque skin retained its characteristic plaque-type elevation and scale; 3), by using a panel of antibodies and immunohistochemical analysis, the overall phenotype of human cell types (including immunocytes) that persisted in the transplanted skin was remarkably similar to the immunophenotype of pretransplanted skin samples; 4), clearly recognized interface zones between human and murine skin within the epidermal and dermal compartments could be identified by routine microscopy and immunostaining, with focal areas of chimerism; and 5), elevated interleukin 8 cytokine levels were present in transplanted pre-psoriatic and psoriatic plaque skin samples. We conclude that there are many similarities between pre- and post-transplanted human samples of normal and psoriatic skin that are grafted onto severe combined immunodeficiency mice. Thus, we propose that this new animal model is appropriate for additional mechanistic- type studies designed to reveal the underlying genetic/etiological abnormality, as well as better illuminate the pathophysiological basis, for this important skin disease.

This article has been cited by other articles:

				N. Bhagavathula, K. C. Nerusu, M. Reddy, C. N. Ellis, A. Chittiboyina, M. Avery, H. A. Pershadsingh, T. W. Kurtz, and J. Varani BP-1107 [{2-[4-(2,4-Dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: A Novel Synthetic Thiazolidinedione That Inhibits Epidermal Hyperplasia in Psoriatic Skin-Severe-Combined Immunodeficient Mouse Transplants after Topical Application J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 996 - 1004. [Abstract] [Full Text] [PDF]

				D. Voskas, N. Jones, P. Van Slyke, C. Sturk, W. Chang, A. Haninec, Y. O. Babichev, J. Tran, Z. Master, S. Chen, et al. A Cyclosporine-Sensitive Psoriasis-Like Disease Produced in Tie2 Transgenic Mice Am. J. Pathol., March 1, 2005; 166(3): 843 - 855. [Abstract] [Full Text] [PDF]

				L S Winterfield, A Menter, K Gordon, and A Gottlieb Psoriasis treatment: current and emerging directed therapies Ann Rheum Dis, March 1, 2005; 64(suppl_2): ii87 - ii90. [Abstract] [Full Text] [PDF]

				K. Tahtis, F.-T. Lee, J. M. Wheatley, P. Garin-Chesa, J. E. Park, F. E. Smyth, Y. Obata, E. Stockert, C. M. Hall, L. J. Old, et al. Expression and Targeting of Human Fibroblast Activation Protein in a Human Skin/Severe Combined Immunodeficient Mouse Breast Cancer Xenograft Model Mol. Cancer Ther., August 1, 2003; 2(8): 729 - 737. [Abstract] [Full Text] [PDF]

				A B Gottlieb Clinical research helps elucidate the role of tumor necrosis factor-{alpha}in the pathogenesis of T1-mediated immune disorders: use of targeted immunotherapeutics as pathogenic probes Lupus, March 1, 2003; 12(3): 190 - 194. [Abstract] [PDF]

				C. N. Ellis, J. Varani, G. J. Fisher, M. E. Zeigler, H. A. Pershadsingh, S. C. Benson, Y. Chi, and T. W. Kurtz Troglitazone Improves Psoriasis and Normalizes Models of Proliferative Skin Disease: Ligands for Peroxisome Proliferator-Activated Receptor-{gamma} Inhibit Keratinocyte Proliferation Arch Dermatol, May 1, 2000; 136(5): 609 - 616. [Abstract] [Full Text] [PDF]

				B. J. Nickoloff and T. Wrone-Smith Injection of Pre-Psoriatic Skin with CD4+ T Cells Induces Psoriasis Am. J. Pathol., July 1, 1999; 155(1): 145 - 158. [Abstract] [Full Text] [PDF]

				K. Hong, A. Chu, B. R. Ludviksson, E. L. Berg, and R. O. Ehrhardt IL-12, Independently of IFN-{gamma}, Plays a Crucial Role in the Pathogenesis of a Murine Psoriasis-Like Skin Disorder J. Immunol., June 15, 1999; 162(12): 7480 - 7491. [Abstract] [Full Text] [PDF]